
FDA Approves a New First Treatment for HER2-Positive Stomach and Esophageal Cancer
The U.S. Food and Drug Administration has approved two regimens built around Ziihera (zanidatamab-hrii) as a first treatment for adults with HER2-positive gastroesophageal adenocarcinoma that cannot…










